Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
American Journal of Cancer Research|March 9, 2022
ONC206 has anti-tumorigenic effects in human ovarian cancer cells and in a transgenic mouse model of high-grade serous ovarian cancerKatherine Tucker, Yajie Yin, Stuart-Allison Staley, et al.
Cancer Biology & Therapy|April 18, 2023
A novel dopamine receptor D2 antagonist (ONC206) potentiates the effects of olaparib in endometrial cancerSarah E Paraghamian, Jianqing Qiu, Gabrielle M Hawkins, et al.
International Journal of Hygiene and Environmental Health|October 20, 2020
Short term effects of air pollutants on hospital admissions for respiratory diseases among children: A multi-city time-series study in ChinaHuihua Yang, Chunxiang Yan, Meng Li, et al.
American Journal of Cancer Research|December 7, 2021
Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancerAllison Staley, Katherine Tucker, Yajie Yin, et al.
International Journal of Molecular Sciences|August 12, 2023
Inhibition of CDK1 by RO-3306 Exhibits Anti-Tumorigenic Effects in Ovarian Cancer Cells and a Transgenic Mouse Model of Ovarian CancerYu Huang, Yali Fan, Ziyi Zhao, et al.
Journal of Cancer Research and Clinical Oncology|August 25, 2022
Asparagus officinalis combined with paclitaxel exhibited synergistic anti-tumor activity in paclitaxel-sensitive and -resistant ovarian cancer cellsXin Zhang, Jiandong Wang, Yali Fan, et al.
Pageof 7